A randomized, double-blind, placebo-controlled multicenter phase 3 trial of niraparib maintenance treatment in patients with advanced ovarian cancer following frontline chemotherapy

Journal article

Open access

Peer reviewed

A. Gonzalez Martin, L.A. Rojas, P.S. Braly, J. Barter, D.M. O'Malley, A.M. Oza, A.F. Haggerty, C. Vulsteke, D.M. Provencher, W. Graybill, …

Annals of oncology, Vol.28, pp.v351-v351

09/2017

Files and links (1)

url

https://doi.org/10.1093/annonc/mdx372.057View

Published (Version of record) Open

5 Record Views

Title: A randomized, double-blind, placebo-controlled multicenter phase 3 trial of niraparib maintenance treatment in patients with advanced ovarian cancer following frontline chemotherapy
Creators: A. Gonzalez Martin - Medica
L.A. Rojas - Avera Health
P.S. Braly - CancerCare
J. Barter - Holy Cross Hospital
D.M. O'Malley - The Ohio State University
A.M. Oza - Princess Margaret Cancer Centre
A.F. Haggerty - Gynecologic Oncology Group
C. Vulsteke - University of Antwerp
D.M. Provencher - Centre Hospitalier de l’Université de Montréal
W. Graybill - Medical University of South Carolina
Y. Li - Tesaro
I.A. Malinowska - Tesaro
M.R. Mirza - Nordic Society of Gynecologic Oncology
I. Vergote - KU Leuven
B. Pothuri - NYU Langone Health
B.J. Monk - The US Oncology Network
Publication Details: Annals of oncology, Vol.28, pp.v351-v351
Publisher: Elsevier Ltd
Identifiers: 991005969156902656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article